Stereotaxis (STXS) Net Cash Flow Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn |
| 10 | Stereotaxis | 187.40 Mn | 172.78 Mn | 3.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 87.16% |
| Dec 31, 2025 | 53.35% |
| Sep 30, 2025 | 60.42% |
| Jun 30, 2025 | -17.40% |
| Mar 31, 2025 | 4.13% |
| Dec 31, 2024 | 24.32% |
| Sep 30, 2024 | -16.86% |
| Jun 30, 2024 | -40.00% |
| Mar 31, 2024 | -5.70% |
| Dec 31, 2023 | -25.52% |
| Sep 30, 2023 | -17.72% |
| Jun 30, 2023 | 114.50% |
| Mar 31, 2023 | -19.04% |
| Dec 31, 2022 | -95.00% |
| Sep 30, 2022 | -37.45% |
| Jun 30, 2022 | -19.71% |
| Mar 31, 2022 | -3.58% |
| Dec 31, 2021 | -48.47% |
| Sep 30, 2021 | -17.66% |
| Jun 30, 2021 | -55.81% |
| Mar 31, 2021 | 57.25% |
| Dec 31, 2020 | -29.51% |
| Sep 30, 2020 | -106.97% |
| Jun 30, 2020 | 85.28% |
| Mar 31, 2020 | 5.29% |
| Dec 31, 2019 | -0.20% |
| Sep 30, 2019 | 70.42% |
| Jun 30, 2019 | 3.01% |
| Mar 31, 2019 | 6.63% |
| Dec 31, 2018 | -16.48% |
| Sep 30, 2018 | -15.98% |
| Jun 30, 2018 | 15.66% |
| Mar 31, 2018 | 34.78% |
| Dec 31, 2017 | 17.81% |
| Sep 30, 2017 | 24.30% |
| Jun 30, 2017 | -19.40% |
| Mar 31, 2017 | 4.55% |
| Dec 31, 2016 | 35.67% |
| Sep 30, 2016 | 23.37% |
| Jun 30, 2016 | 18.29% |
| Mar 31, 2016 | 3.84% |
| Dec 31, 2015 | -31.87% |
| Sep 30, 2015 | 45.34% |